MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain.

OA: closed
📄 Open PDF View on PubMed View at publisher

Abstract

The application of high intense focused ultrasound (HIFU) is currently the subject of many experimental and clinical trials. The combination of HIFU with MRI guidance known as MR-guided focused ultrasound (MRgFUS) appears to be particularly promising to ablate tissues located deep in the brain. The method can be the beginning of interventional neurology and an important alternative to neurosurgery. Studies conducted to date show the effectiveness of the method both in chronic diseases and in emergency cases. The safety and effectiveness of this method have been observed in parkinsonian and essential tremor as well as in neuropathic pain. The procedure does not require anaesthesia. Ionizing radiation is not used and there is no risk of cumulative dose. Such advantages may result in low complication rates and medical justification for further development of MRgFUS.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (35)

Source provenance

crossref
last seen: 2026-05-29T01:00:05.247898+00:00
europepmc
last seen: 2026-07-14T06:08:30.651965+00:00
unpaywall
last seen: 2026-07-14T06:42:26.817772+00:00